Company intelligence / Profile preview

ConKay Medical Systems

Pleasanton, California, United Statesconkaymedical.com ↗

Ownership: Private
Development stage: Preclinical

Overview

ConKay Medical Systems is developing a minimally invasive, one-size-fits-all annular repair catheter system designed to treat tricuspid regurgitation by reducing the diameter of the tricuspid valve annulus. The device aims to replicate surgical annuloplasty without open-heart surgery and is intended for patients who are not candidates for current devices due to large or complex anatomy. As of early 2024, the company has raised $1.8M in seed funding and is preparing for first-in-human clinical trials; no published clinical results yet.

Therapeutic areas: Cardiovascular
Modalities: DeviceCatheter-based therapy
Industry: Surgical Medical Devices

Partnerships

Unorthodox VenturesSCP VenturesWS Investment Company (investors/partners)

Beyond the preview

Go deeper on ConKay Medical Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ConKay Medical Systems.

Explore the full profile